Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2006, Article ID 15947, 4 pages
http://dx.doi.org/10.1155/SRCM/2006/15947
Clinical Study

A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas

1Gynecological Oncology Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
2Melanoma-Sarcoma Services, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA

Received 22 July 2005; Revised 26 July 2006; Accepted 17 October 2006

Copyright © 2006 Sibyl E. Anderson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A Jemal, R Siegel, E Ward et al., “Cancer statistics, 2006,” CA: A Cancer Journal for Clinicians, vol. 56, no. 2, pp. 106–130, 2006. View at Google Scholar
  2. M F Brennan, S Singer, R G Maki, and B O'Sullivan, “Soft tissue sarcoma,” in Cancer: Principles & Practice of Oncology, V T Jr DeVita, S Hellman, and S A Rosenberg, Eds., pp. 1581–1637, Lippincott Williams & Wilkins, Philadelphia, Pa, 7th edition, 2005. View at Google Scholar
  3. K H Antman and A D Elias, “Chemotherapy of advanced soft-tissue sarcomas,” Seminars in Surgical Oncology, vol. 4, no. 1, pp. 53–58, 1988. View at Publisher · View at Google Scholar
  4. L Svancarova, J Y Blay, I R Judson et al., “Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group,” European Journal of Cancer, vol. 38, no. 4, pp. 556–559, 2002. View at Publisher · View at Google Scholar
  5. M L Hensley, R G Maki, E Venkatraman et al., “Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial,” Journal of Clinical Oncology, vol. 20, no. 12, pp. 2824–2831, 2002. View at Publisher · View at Google Scholar
  6. J A Gottlieb, R S Benjamin, L H Baker et al., “Role of DTIC (NSC-45388) in the chemotherapy of sarcomas,” Cancer Treatment Reports, vol. 60, no. 2, pp. 199–203, 1976. View at Google Scholar
  7. M Casanova, A Ferrari, F Spreafico et al., “Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma,” Cancer, vol. 94, no. 12, pp. 3263–3268, 2002. View at Publisher · View at Google Scholar
  8. G Nasti, D Errante, R Talamini et al., “Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma: results of a phase II study,” Journal of Clinical Oncology, vol. 18, no. 7, pp. 1550–1557, 2000. View at Google Scholar
  9. P Fidias, G Demetri, and D Harmon, “Navelbine shows activity in previously treated sarcoma patients: phase II results from MGH/Dana Farber/Partner's Cancer Care Study,” Proceedings of the American Society for Clinical Oncology, vol. 17, p. 1977, 1998. View at Google Scholar
  10. M Van Glabbeke, J Verweij, I Judson, and O S Nielsen, “EORTC Soft Tissue and Bone Sarcoma Group. Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas,” European Journal of Cancer, vol. 38, no. 4, pp. 543–549, 2002. View at Publisher · View at Google Scholar
  11. K M Leu , L J Ostruszka, D Shewach et al., “Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma,” Journal of Clinical Oncology, vol. 22, no. 9, pp. 1706–1712, 2004. View at Publisher · View at Google Scholar
  12. J O Bay, I Ray-Coquard, J Fayette et al., “Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis,” International Journal of Cancer, vol. 119, no. 3, pp. 706–711, 2006. View at Publisher · View at Google Scholar
  13. R G Maki, M L Hensley, J K Wathen et al., “A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS),” Journal of Clinical Oncology, vol. 24, no. 18S, p. 9514, 2006. View at Google Scholar
  14. F Grosso, G D Demetri, J-Y Blay et al., “Patterns of tumor response to trabectedin (ET-743) in myxoid liposarcomas,” Journal of Clinical Oncology, vol. 24, no. 18S, p. 9511, 2006. View at Google Scholar